T. Wilkinson (Southampton, United Kingdom), S. Sethi (Buffalo, United States of America)
Human metapneumovirus involved in acute exacerbations in COPD patients?
M. Vanspauwen, F. Franssen, C. Bruggeman, E. Wouters, C. Linssen (Maastricht, Horn, Netherlands)
|   |
Amoxicillin concentrations in sputum in relation to betalactamase activity in COPD patients
R. van der Zanden, P. van der Valk, R. Hendrix, J. van der Palen, K. Movig, M. Brusse-Keizer (Maastricht, Enschede, Netherlands)
| |
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study
F. Blasi, C. Fornari, F. Di Stasi, S. Conti, L. G. Mantovani, L. Merlino, S. Aliberti, G. Cesana (Milan, Monza, Naples, Italy)
| |
Safety and pharmacokinetics of multiple-dose ciprofloxacin dry powder for inhalation in patients with moderate or severe COPD
H. Stass, P. Badorrek, J. Hohlfeld, N. Krug, J. Nagelschmitz, T. Welte (Wuppertal, Hannover, Germany)
| |
Does presence of multiple viruses in the stable state predispose COPD patients to exacerbations?
M. Vanspauwen, F. Franssen, C. Bruggeman, E. Wouters, C. Linssen (Maastricht, Horn, Netherlands)
| |
The relationship between PBMC secretion of IFN-alpha following TLR7 and TLR9 activation and lung function in COPD
V. Mistry, M. Bafadhel, S. McKenna, S. Terry, C. Brightling (Leicester, United Kingdom)
| |
Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
M. Pancholi, M. Bafadhel, S. McKenna, S. Terry, V. Mistry, C. Newby, I. Pavord, C. Brightling (Leicester, United Kingdom)
| |
Induction of cathelicidin (LL-37) in rhinovirus-induced COPD exacerbations
R. Sotero, P. Mallia, J. Footitt, M. B. Trujillo-Torralbo, T. Kebadze, C. Marco, A. Papi, G. Pelaia, R. Maselli, S. Johnston (London, United Kingdom; Catanzaro, Ferrara, Italy)
| |
Exacerbation frequency is related to PEF self-similarity in COPD
G. Donaldson, T. Seemungal, J. Hurst, J. Wedzicha (London, United Kingdom; St. Augustine, Trinidad And Tobago)
| |
The role of respiratory virus infection in COPD exacerbations
X. Pomares, S. Capilla, C. Montón, D. Mariscal, M. A. Marcos, M. Espasa, E. Monsó, M. Gallego (Sabadell, Barcelona, Spain)
| |
Presence of pneumocystis jiroveci colonization in patients with COPD
M. Vanspauwen, F. Franssen, C. Bruggeman, E. Wouters, C. Linssen (Maastricht, Horn, Netherlands)
| |
Microbiological efficacy of combined use of vaccines against S. pneumoniae, H. influenzae type B in patients with a COPD
A. Protasov, A. Zhestkov, M. Kostinov, A. Ryzhov (Samara, Moscow, Russian Federation)
| |
Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations
A. Martynova, E. Nosuch, A. Sheparyov (Vladivostok, Russian Federation)
| |
Characteristic of cytokines levels of blood and sputum in COPD exacerbation
S. Nesterovich, E. Bukreeva (Tomsk, Russian Federation)
| |
Bronchial brush-biopsies cells in dependence on infectional agent species at COPD exacerbation
S. Nesterovich, E. Bukreeva (Tomsk, Russian Federation)
| |
Modification of cell mediated immune-response in patients treated with a polyvalent mechanical bacterial lysate
F. Braido, E. Traggiai, G. Lanzilli, G. Bazorro, C. Folli, V. Garelli, A. M. Riccio, G. Melioli (Genoa, Rome, Italy)
| |
Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
I. Y. Tseimakh, A. P. Momot, G. I. Kostjuchenko, T. A. Kornilova, I. P. Kramar, J. A. Filonova, A. G. Chuchalin (Barnaul, Moscow, Russian Federation)
| |
Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization
R. Blavia, A. Flor, I. Serra, M. Morta, D. Estivill, R. Trullas, D. Perich, E. Martin, C. Perez, E. Marquilles (Manresa, Spain)
| |